The Michael J. Fox Foundation has expanded its trial platform to include patients with atypical parkinsonism, an umbrella term for various rare diseases.
The Scripps Research Institute has rolled out DataDirect Networks’ data management system across its cryo-electron microscopy research teams.
Researchers have more than doubled the known number of brain regions using a mix of magnetic resonance imaging and data-derived algorithms.
N-of-One has raised $7 million to improve its oncology precision medicine system and expand its sales operation globally.
Biogen has made Medidata Rave its primary clinical trial technology platform, continuing the shift in power in the eClinical market.
Bioz has exited stealth with funding from 5AM Ventures and a platform it sees as taking some of the drudgery and guesswork out of sourcing research products.
PatientsLikeMe has lured Marni Hall away from the FDA. Hall will now work to turn patient-reported data into tools that improve research and health outcomes.
HHS has set up a challenge to identify ways in which blockchain can support privacy, security and scalability in health IT and research data.
GlaxoSmithKline has set up a rheumatoid arthritis clinical trial running on Apple’s ResearchKit framework.
Nostrum has spun out of a pair of Spanish research institutions with ambitions to use supercomputer-powered computational simulations to improve drug discovery.